IP Library › Granted Patent US 9,725,681
Granted Patent B2
US 9,725,681 · App. 15/021,720 · Granted Aug 8, 2017

Aqueous proteolytic enzyme-containing formulation for the cleaning of hard surfaces

Inventors: Mike Peters (Hamburg, DE); Judith Heidel (Pinneberg, DE); Katrin Steinhauer (Hamburg, DE); Dana Kunde (Tangstedt, DE)
Assignee: L'AIR LIQUIDE SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE
C11D3/0073C11D1/146C11D1/22C11D1/662C11D1/83C11D3/2041C11D3/2065C11D3/2086C11D3/28C11D3/38618C11D11/0029
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,725,681
App. No.
15/021,720
Granted
Aug 8, 2017
Kind
B2
Abstract

An aqueous formulation includes a) one or more proteolytic enzymes, b) one or more anionic surfactants, c) one or more non-ionic surfactants, d) one or more corrosion inhibitors, e) one or more multivalent aliphatic alcohols, f) one or more complexing agents, and g) one or more of para-hydroxybenzoic acid and esters thereof. The pH value of the formulation is in the range of from 9. to 12.5. The formulation is used in the mechanical cleaning of hard surfaces, in particular of medical instruments, and is preferably silicate free.

Claims (31)

1. Aqueous formulation which comprises:

a)—One or more proteolytic enzymes, wherein the total quantity of the component a), relative to the weight of the formulation, amounts to from 0.03 to 1.0% by weight,

b)—One or more anionic surfactants, wherein the total quantity of the component b), relative to the weight of the formulation, amounts to from 0.5 to 15% by weight,

c)—One or more non-ionic surfactants, wherein the total quantity of the component c), relative to the weight of the formulation, amounts to from 0.1 to 12% by weight,

d)—One or more corrosion inhibitors, wherein the total quantity of the component d), relative to the weight of the formulation, amounts to from 0.050 to 1.0% by weight,

e)—One or more multivalent aliphatic alcohols, wherein the total quantity of the component e), relative to the weight of the formulation, amounts to from 5.0 to 60% by weight,

f)—One or more complexing agents, wherein the total quantity of the component f), relative to the weight of the formulation, amounts to from 0.1 to 15% by weight, and

g)—one or more of para-hydroxybenzoic acid and the esters thereof, wherein the total quantity of the component g), relative to the weight of the formulation, amounts to from 0.05 to 3.0% by weight,

wherein the pH value of said aqueous formulation is in the range of from 9.5 to 12.5.

2. Formulation according to claim 1 , wherein the proteolytic enzyme is selected from the group consisting of Properase, Savinase and Esperase.

3. Formulation according to claim 1 , wherein the component a) is present in a quantity of from 0.05 to 0.6% by weight, relative to the weight of the formulation.

4. Formulation according to claim 1 , wherein the component b) is present in a quantity of from 1.0 to 12% by weight, relative to the weight of the formulation.

5. Formulation according to claim 1 , wherein the component c) is present in a quantity of from 0.2 to 9.0% by weight, relative to the weight of the formulation.

6. Formulation according to claim 1 , wherein the component d) is present in a quantity of from 0.08 to 0.7% by weight, relative to the weight of the formulation.

7. Formulation according to claim 1 , wherein the component e) is present in a quantity of from 10 to 60% by weight, relative to the weight of the formulation.

8. Formulation according to claim 1 , wherein the component f) is present in a quantity of from 0.5 to 6% by weight, relative to the weight of the formulation.

9. Formulation according to claim 1 , wherein the component g) is present in a quantity of from 0.1 to 2.0% by weight, relative to the weight of the formulation.

10. Aqueous formulation according to claim 1 , which comprises:

a)—From 0.05 to 0.6% by weight, relative to the weight of the formulation, of one or more proteolytic enzymes, selected from the group consisting of Properase, Savinase and Esperase;

b)—From 1.0 to 12% by weight, relative to the weight of the formulation, of one or more anionic surfactants, selected from the group consisting of alkyl sulphates, alkyl sulphonates, aryl sulphates and aryl sulphonates;

c)—From 0.2 to 9.0% by weight relative to the weight of the formulation of one or more non-ionic surfactants, selected from the group consisting of fatty alcohols alkoxylates and fatty alcohol glucosides,

d)—From 0.08 to 0.7% by weight, relative to the weight of the formulation, of one or more corrosion inhibitors, selected from the group consisting of 1H-benzotriazole and N,N-bis(2-ethylhexyl)-1H-1,2,4-triazol-1-methanamine;

e)—From 10 to 60% by weight, relative to the weight of the formulation, of one or more multivalent aliphatic alcohols selected from the group consisting of alkanetriols and alkanediols;

f)—From 0.5 to 6% by weight, relative to the weight of the formulation, of one or more complexing agents selected the group consisting of from nitrilotriacetic acid salts, phosphonobutane tricarboxylic acids salts, methylglycinediacetic acid salts and ethylenediaminetetracetic acid salts, and

g)—From 0.1 to 2.0% by weight, relative to the weight of the formulation, of one or more of para-hydroxybenzoic acid and the esters thereof selected from the group consisting of methyl, ethyl, propyl and butyl esters of para-hydroxybenzoic acid.

11. Formulation according to claim 1 , wherein the quantity of water h) amounts to from 15 to 90% by weight.

12. Formulation according to claim 1 , which it further comprises i) one or more dispersion agents.

13. Formulation according to claim 1 , which it further comprises k) one or more univalent aliphatic alcohols.

14. Method for the mechanical cleaning of hard surfaces, comprising the step of cleaning said hard surface with an aqueous dilution of the formulation according to claim 1 , said dilution being at a concentration in the range of from 0.5 to 20 ml/l.

15. Method according to claim 14 , wherein the hard surface is a medical instrument.

16. Method according to claim 15 , wherein said medical instrument is an endoscope.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2019
From: L'AIR LIQUIDE SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE
To: SCHULKE & MAYR GMBH
Reel/Frame 048965/0875 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2016
From: PETERS, MIKE; HEIDEL, JUDITH; STEINHAUER, KATRIN; KUNDE, DANA
To: L'AIR LIQUIDE SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE
Reel/Frame 038098/0366 →
Priority Claims (1)
DE 10 2013 218 449 · Sep 13, 2013 · national
Continuity (1)
Related Publication 20160222317A1 · Aug 4, 2016